UCL Business PLC - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

UCL Business PLC (UCLB), a subsidiary of University College London is a technology transfer company that supports and markets research and innovations. The company offers licensing technologies and innovations, creates shared risk joint venture businesses, and promotes and supports the transfer into industry of expertise and knowledge over a wide range of disciplines. It provides commercial expertise, legal advice, and administrative support. UCLB operates in creating spinout businesses in new industries. The company offers services such as contractual advice and formalization, business plan development, and others. It also provide technology licensing, contract negotiation and project management services. The company serves biopharma, engineering and physical sciences companies. UCLB is headquartered in London, the UK.

UCL Business PLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCL Business PLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UCL Business PLC, Medical Devices Deals, 2012 to YTD 2018 9
UCL Business PLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UCL Business PLC, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Orchard Therapeutics Raises USD31 Million in Series A Venture Financing 12
Puridify Raises USD3.4 Million in Series A Financing 13
Autifony Therapeutics Raises USD12.3 Million in Extended Series A Financing 14
Puridify Raises USD1.43 Million in Seed Funding 15
Canbex Therapeutics Raises US$3 Million In Venture Financing 16
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 17
Partnerships 18
UCL Business Forms Joint Venture with Syncona 18
Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations 19
Licensing Agreements 20
Autolus Enters into Licensing Agreement with UCL Business 20
MeiraGTx Enters into Licensing Agreement with UCL Business 21
MeiraGTx Enters into Licensing Agreement with UCL Business 22
Autolus Amends Licensing Agreement with UCL Business 23
BioKier Enters into Licensing Agreement with UCL Business 24
Oxford Pharmascience Extends Licensing Agreement With UCL Business 25
Oxford Pharmascience Enters Into Licensing Agreement With UCL Business For Drug Delivery Technology 26
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 27
UCL Business PLC - Key Competitors 28
UCL Business PLC - Key Employees 29
UCL Business PLC - Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 30
Recent Developments 31
Government and Public Interest 31
Mar 28, 2018: Liverpool researchers to help transform treatment for children with arthritis and uveitis 31
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List Of Tables


UCL Business PLC, Pharmaceuticals & Healthcare, Key Facts 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCL Business PLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCL Business PLC, Deals By Therapy Area, 2012 to YTD 2018 8
UCL Business PLC, Medical Devices Deals, 2012 to YTD 2018 9
UCL Business PLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orchard Therapeutics Raises USD31 Million in Series A Venture Financing 12
Puridify Raises USD3.4 Million in Series A Financing 13
Autifony Therapeutics Raises USD12.3 Million in Extended Series A Financing 14
Puridify Raises USD1.43 Million in Seed Funding 15
Canbex Therapeutics Raises US$3 Million In Venture Financing 16
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 17
UCL Business Forms Joint Venture with Syncona 18
Cell Therapy Catapult Forms Catapult Therapy TCR with UCL Business and Imperial Innovations 19
Autolus Enters into Licensing Agreement with UCL Business 20
MeiraGTx Enters into Licensing Agreement with UCL Business 21
MeiraGTx Enters into Licensing Agreement with UCL Business 22
Autolus Amends Licensing Agreement with UCL Business 23
BioKier Enters into Licensing Agreement with UCL Business 24
Oxford Pharmascience Extends Licensing Agreement With UCL Business 25
Oxford Pharmascience Enters Into Licensing Agreement With UCL Business For Drug Delivery Technology 26
University College London Business Enters Into Licensing Agreement With TAP Biosystems For RAFT Technology 27
UCL Business PLC, Key Competitors 28
UCL Business PLC, Key Employees 29
UCL Business PLC, Subsidiaries 30
UCL Business PLC, Joint Venture 30

List Of Figures


UCL Business PLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UCL Business PLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UCL Business PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UCL Business PLC, Medical Devices Deals, 2012 to YTD 2018 9

Nucleus Software Exports Ltd (NUCLEUS) - Financial and Strategic SWOT Analysis Review

Nucleus Software Exports Ltd (NUCLEUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Equipos Nucleares SA - Strategic SWOT Analysis Review

Equipos Nucleares SA - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

UCL Business PLC - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

UCL Business PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe UCL Business PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

UCL Business PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

UCL Business PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportMarketlines UCL Business PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available